5 things to watch on the ASX 200 on Friday

Mesoblast limited (ASX:MSB) and Woodside Petroleum Limited (ASX:WPL) shares will be on watch on the ASX 200 on Friday…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Thursday the S&P/ASX 200 Index (ASX: XJO) returned to form and raced notably higher. The benchmark index climbed 1% to 5,872.9 points.

Will the market be able to build on this on Friday? Here are five things to watch:

ASX 200 expected to fall.

It looks set to be a disappointing end to the week for the ASX 200 despite a solid night of trade on Wall Street. According to the latest SPI futures, the ASX 200 is poised to open the day 26 points or 0.45% lower this morning. Overnight the Dow Jones rose 0.1%, the S&P 500 climbed 0.5%, and the Nasdaq stormed 1.4% higher.

Oil prices sink lower

Energy shares such as Beach Energy Ltd (ASX: BPT) and Woodside Petroleum Limited (ASX: WPL) could tumble lower on Friday after oil prices sank lower.  According to Bloomberg, the WTI crude oil price is down 3.9% to US$38.65 a barrel and the Brent crude oil price has dropped 3.5% to US$40.83 a barrel. A weak demand outlook and higher than expected OPEC production weighed on prices.

Gold price rises.

Gold miners such as Evolution Mining Ltd (ASX: EVN) Northern Star Resources Ltd (ASX: NST) could end the week on a positive note after the gold price pushed higher. According to CNBC, the spot gold price is up 0.8% to US$1,910.60 an ounce amid U.S. stimulus hopes.

Tech shares could storm higher.

It could be a good day for tech shares such as Afterpay Ltd (ASX: APT) and Appen Ltd (ASX: APX) after their U.S. peers stormed higher overnight. On Wall Street the tech-focused Nasdaq index recorded a strong 1.4% gain. The local sector has a tendency to follow the lead of the Nasdaq.

Mesoblast on watch.

It will be worth keeping an eye on the Mesoblast limited (ASX: MSB) share price on Friday. While the company isn't expecting to make an announcement on whether the US FDA has approved its remestemcel-L (RYONCIL) product for paediatric patients with steroid-refractory acute graft versus host disease until Monday, there's always a chance the FDA will move quicker than expected and give its verdict before the market open. The Mesoblast share price will remain halted until its release.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO and Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX was back to the races this Tuesday.

Read more »

Blue % sign with white dollar signs.
ASX Share Market News

ASX 200 eyeing new record closing high as RBA keeps interest rates on hold. Now what?

Mortgage holders and ASX investors have received the interest rate pause they were hoping for.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

3 ASX shares to buy as the market gathers pace: experts

Looking for investment inspiration in the rising market?

Read more »

A woman is excited as she reads the latest rumour on her phone.
ASX Share Market News

Why Core Lithium, Newmont and Life360 shares are turning heads on Tuesday

Newmont, Life360, and Core Lithium shares are making waves today. But why?

Read more »

Man and woman sitting at table with the man looking a bit puzzled at his laptop.
Broker Notes

Buy, hold, sell: APA Group, Amcor, Mineral Resources shares

Let's take a look at some new buy, hold, and sell calls from James Bills at Shaw and Partners.

Read more »

ASX 200 shares broker downgrade origami paper fortune teller with buy hold sell and dollar sign options
Broker Notes

Amcor shares have surged 30% since May. Buy, hold or sell?

Two leading analysts offer their forecasts for Amcor’s rebounding shares.

Read more »

The words short selling in red against a black background
ASX Share Market News

Why this expert is betting against 4DMedical and DroneShield shares

A leading expert believes DroneShield and 4DMedical shares have further to fall. But why?

Read more »

A happy young couple celebrate a win by jumping high above their new sofa.
Broker Notes

This ASX 200 stock is expected to rise 22% in the next 12 months – Expert

This stock is a rebound candidate.

Read more »